Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
American Journal of Hematology
|
July 7, 2016
Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
Darko Antic, Natasa Milic, Srdjan Nikolovski, et al.
American Journal of Hematology
|
April 10, 2014
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia
Irene M Ghobrial, Thomas E Witzig, Morie Gertz, et al.
Bone Marrow Transplantation
|
October 6, 2022
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
Charalampos Charalampous, Utkarsh Goel, Morie Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 11, 2015
Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic
Muhammad A Mir, Prashant Kapoor, Shaji Kumar, et al.
Leukemia & Lymphoma
|
May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation
Morie A Gertz, Rahma Warsame, Eli Muchtar, et al.
World Journal of Transplantation
|
July 1, 2016
Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience
Martha Grogan, Morie Gertz, Arleigh McCurdy, et al.
American Journal of Hematology
|
July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products
Sarah Dingli, Paul Rothweiler, Moritz Binder, et al.
American Journal of Hematology
|
November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival
Martha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
S Vincent Rajkumar, Suzanne Hayman, Morie A Gertz, et al.
Blood Cancer Journal
|
May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myeloma
Sarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
American Journal of Hematology
|
July 7, 2016
Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
Darko Antic, Natasa Milic, Srdjan Nikolovski, et al.
American Journal of Hematology
|
April 10, 2014
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia
Irene M Ghobrial, Thomas E Witzig, Morie Gertz, et al.
Bone Marrow Transplantation
|
October 6, 2022
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
Charalampos Charalampous, Utkarsh Goel, Morie Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 11, 2015
Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic
Muhammad A Mir, Prashant Kapoor, Shaji Kumar, et al.
Leukemia & Lymphoma
|
May 13, 2022
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation
Morie A Gertz, Rahma Warsame, Eli Muchtar, et al.
World Journal of Transplantation
|
July 1, 2016
Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience
Martha Grogan, Morie Gertz, Arleigh McCurdy, et al.
American Journal of Hematology
|
July 15, 2025
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products
Sarah Dingli, Paul Rothweiler, Moritz Binder, et al.
American Journal of Hematology
|
November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival
Martha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
S Vincent Rajkumar, Suzanne Hayman, Morie A Gertz, et al.
Blood Cancer Journal
|
May 7, 2025
The ratio of brain to liver glucose activity and disease activity in multiple myeloma
Sarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Page
of 8